Panagiota Iliopoulou

Title: Innovations by Panagiota Iliopoulou

Introduction

Panagiota Iliopoulou is an accomplished inventor based in San Carlos, California. She has made significant contributions to the field of transplantation through her innovative research and patents. With a total of two patents to her name, Iliopoulou is recognized for her work in reducing undesirable immune responses associated with tissue or organ transplantation.

Latest Patents

Iliopoulou's latest patents focus on the blockade of RGMB to reduce transplantation-associated inflammation and immune responses. The first patent, titled "Blockade of RGMB for reducing transplantation-associated inflammation leading to loss of function of a transplanted organ in a graft recipient," highlights how RGMB antagonists can mitigate undesirable immune responses. The second patent, "Blockade of RGMb for reducing transplantation-associated immune responses," further emphasizes the role of RGMB antagonists in improving transplantation outcomes.

Career Highlights

Panagiota Iliopoulou is affiliated with Leland Stanford Junior University, where she conducts her research. Her work has garnered attention for its potential to enhance the success rates of organ transplants and improve patient outcomes.

Collaborations

Iliopoulou collaborates with notable colleagues, including Everett Hurteau Meyer and Rosemarie Dekruyff, who contribute to her research endeavors.

Conclusion

Panagiota Iliopoulou's innovative work in transplantation research is paving the way for advancements in organ transplant success and patient care. Her contributions through her patents are significant in the field of immunology and transplantation.